40
Participants
Start Date
January 3, 2022
Primary Completion Date
March 1, 2022
Study Completion Date
March 1, 2022
YpsoPump® insulin pump system
The subjects will receive a CE-certified mylife™ YpsoPump® insulin pump system that allows detailed logging of pressure data. Data will then be analysed in silico comparing the new occlusion detection algorithm with the common occlusion detection algorithm.
Institut für Diabetes-Technologie, Forschungs- und Entwicklungsgesellschaft mbH an der Universität Ulm, Ulm
Universitätsklinik für Diabetologie, Endokrinologie Ernährungsmedizin & Metabolismus, Bern
Collaborators (1)
DCB Research AG
OTHER
Ypsomed Diabetes Care AG
INDUSTRY